Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials ; volume:19 ; number:1 ; day:30 ; month:9 ; year:2020 ; pages:1-11 ; date:12.2020
Cardiovascular diabetology ; 19, Heft 1 (30.9.2020), 1-11, 12.2020
- Urheber
-
Husain, Mansoor
Bain, Stephen C.
Holst, Anders Gaarsdal
Mark, Thomas
Rasmussen, Søren
Lingvay, Ildiko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-020-01106-4
- URN
-
urn:nbn:de:101:1-2020111513341018901046
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Husain, Mansoor
- Bain, Stephen C.
- Holst, Anders Gaarsdal
- Mark, Thomas
- Rasmussen, Søren
- Lingvay, Ildiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes
Integrated management of cardiovascular risk : Cardiovascular Disease Programme
Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
Biomarkers of cardiovascular risk across phenotypes of osteoarthritis
Localization of fat depots and cardiovascular risk
Epidemiology and cardiovascular risk factors of aortic stenosis
Long Working Hours and Risk of Cardiovascular Disease
Prevalence of high cardiovascular risk by economic sector
Gallstone Disease and the Risk of Cardiovascular Disease
The challenge of choosing in cardiovascular risk management
Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes
Integrated management of cardiovascular risk : Cardiovascular Disease Programme
Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
Biomarkers of cardiovascular risk across phenotypes of osteoarthritis
Localization of fat depots and cardiovascular risk
Epidemiology and cardiovascular risk factors of aortic stenosis
Long Working Hours and Risk of Cardiovascular Disease
Prevalence of high cardiovascular risk by economic sector
Gallstone Disease and the Risk of Cardiovascular Disease
The challenge of choosing in cardiovascular risk management
Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes
Integrated management of cardiovascular risk : Cardiovascular Disease Programme
Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
Biomarkers of cardiovascular risk across phenotypes of osteoarthritis
Localization of fat depots and cardiovascular risk
Epidemiology and cardiovascular risk factors of aortic stenosis
Long Working Hours and Risk of Cardiovascular Disease
Prevalence of high cardiovascular risk by economic sector
Gallstone Disease and the Risk of Cardiovascular Disease